The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of bevacizumab, erlotinib, and atezolizumab in subjects with advanced hereditary leiomyomatosis and renal cell cancer (HLRCC) associated or sporadic papillary renal cell cancer (pRCC).
 
Gabriela Liliana Bravo Montenegro
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
Cheryl Ann Pickett-Gies
No Relationships to Disclose
 
Lisa Mac
No Relationships to Disclose
 
Julia C. Friend
No Relationships to Disclose
 
Erin Purcell
No Relationships to Disclose
 
Srivandana Akshintala
No Relationships to Disclose
 
John Glod
Research Funding - AdaptImmune; GlaxoSmithKline/Adaptimmune (Inst)
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Exelixis; Janssen; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Sorrento Therapeutics; Tempus; Vividion Therapeutics
Research Funding - Bayer (Inst); Pfizer (Inst); Tempus (Inst)
 
Mehmet Asim Bilen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; Seagen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)
 
Alexis Rompre-Brodeur
No Relationships to Disclose
 
Brad Webster
No Relationships to Disclose
 
Nikhil Gopal
No Relationships to Disclose
 
Ashkan A. Malayeri
Employment - Novartis (I)
Consulting or Advisory Role - AstraZeneca (I); Radimmune (I); Reflexion Medical (I)
 
Maria Merino
No Relationships to Disclose
 
Zachary Kozel
No Relationships to Disclose
 
Sandeep Gurram
No Relationships to Disclose
 
W. Marston Linehan
No Relationships to Disclose
 
Ramaprasad Srinivasan
Research Funding - AstraZeneca (Inst); Calithera Biosciences (Inst); Peloton Therapeutics (Inst); Sanofi (Inst)